E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
The use of transfer factors in chronic fatigue syndrome: prospects and problems.
Levine, P H · Biotherapy (Dordrecht, Netherlands) · 1996 · DOI
Quick Summary
ME/CFS often starts with a viral infection and some people have ongoing herpes virus activity. This article discusses transfer factors—a type of immune therapy—that might help fight these viruses and improve symptoms. The authors explain why we need better-designed studies to test if this treatment actually works.
Why It Matters
This editorial highlights the potential role of persistent viral infections in ME/CFS and proposes a biological rationale for immunotherapy. It also identifies critical gaps in trial design that have hampered understanding of treatment efficacy, providing a framework for future research.
Observed Findings
- Transfer factors with specific activity against herpes viruses (EBV, HHV-6, CMV) have been documented
- Some ME/CFS patients present with acute viral illness onset resembling flu-like infection
- Specific herpes viruses can be identified at disease onset in certain cases
- Recent reports suggest transfer factor may have a beneficial role in ME/CFS
Inferred Conclusions
- Persistent viral activity may contribute to ME/CFS symptom perpetuation in some patients
- Transfer factors represent a theoretically sound intervention targeting putative viral drivers
- Current evidence is insufficient to determine transfer factor efficacy without rigorous randomized trials
- Patient heterogeneity and disease sub-classification are essential for meaningful clinical trial outcomes
Remaining Questions
- Which ME/CFS patient subgroups (if any) have persistent herpes virus activity driving symptoms?
- Do transfer factors reduce viral reactivation and improve symptoms in randomized controlled trials?
- What are appropriate biomarkers and clinical endpoints for measuring transfer factor efficacy?
What This Study Does Not Prove
This is an editorial commentary, not a clinical trial, so it presents no direct evidence that transfer factors are effective for ME/CFS. The article does not establish causation between herpes viruses and symptom perpetuation, only that associations exist. It does not settle whether transfer factors should be used in clinical practice.
Tags
Symptom:Cognitive DysfunctionUnrefreshing SleepPainFatigue
Phenotype:Infection-Triggered
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- DOI
- 10.1007/BF02628661
- PMID
- 8993762
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →